Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase NA 7Phase 1 6Phase 2/3 3Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Radiodermatitis 1Polycystic Ovary Syndrome 1Condylomata Acuminata 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Curcumin × Clear all
NCT07278128 2025-12-11

Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial

Tarbiat Modarres University

Phase 2/3 Completed
74 enrolled

Polycystic Ovary Syndrome

NCT06281353 2024-02-28

The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue

Indonesia University

Phase 2/3 Completed
78 enrolled

Condylomata Acuminata

NCT01246973 2016-03-07

Oral Curcumin for Radiation Dermatitis

University of Rochester

Phase 2/3 Completed
686 enrolled 8 charts

Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡